Company / Current Liabilities
Atea Pharmaceuticals, Inc. Current Liabilities History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$18.5M
FY2022
5-year range
$18.5M / $315.8M
FY2020-FY2022
Trend
-67.5%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $316M to $18M over the past 2 years.
Based on SEC 10-K filings.
$18M in FY2022.
Improved from $316M to $18M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, current liabilities decreased 67.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 10.30 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $18.5M | -67.5% |
| FY2021 | $56.9M | -82.0% |
| FY2020 | $315.8M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026